Clinical trials
Cerebrovascular Disorders trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 9 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 9 |
| University Hospital, Caen | 2 |
| University Hospital, Rouen | 2 |
| Bayer | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Cogentus Pharmaceuticals | 1 |
| Eli Lilly and Company | 1 |
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
| Hospices Civils de Lyon | 1 |
| Hovid Berhad | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebrovascular Disorders | 32 |
| Stroke | 19 |
| Ischemic Stroke | 8 |
| Vascular Diseases | 8 |
| Brain Diseases | 7 |
| Cardiovascular Diseases | 6 |
| Brain Ischemia | 4 |
| Nervous System Diseases | 4 |
| Central Nervous System Diseases | 3 |
| Dementia | 3 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.